It looks like nothing was found at this location. Maybe try one of the links below or a search?
Popular Articles:
-
Response to EPO consultation: Don’t impose oral proceedings by videoconference
-
Quality at the EPO – One Modest and one Serious Proposal
-
‘Opposition against Unitary Patent comes from fearful lawyers and critics who only have a theoretical interest’
-
Leading German patent law firms criticize European Patent Office
-
UPC: four reasons on why the PPA is not legally in force
-
The EPO’s Vision (V) – Trust
Recent Articles:
-
UPC “saisie-contrefaçon” Part II: the “OERLIKON” case
-
UPC “saisie-contrefaçon” Part I: the texts
-
The Role of Scientific Advisers in the English Patents Court
-
Trying to Make Sense of the Oracle of G 2/21: T 116/18 vs. T 681/21
-
Patent case: NanoString Technologies vs. 10x Genomics and President and Fellows of Harvard College, UPC
-
Patent case: Judgment no. 141/2023 dated 5 December 2023, Spain
Random Articles:
-
Circular fluorescent lamp/Osram, European Patent Office (EPO Board of Appeal), 17 March 2011
-
Latvia ratifies Unified Patent Court Agreement
-
Portugal: AIM generic medicament, Supreme Court of Justice of Portugal, 747/13.1YRLSB.S1, 20 May 2015
-
Settlement for former SUEPO leader, social tensions remain at the EPO
-
Patent case: Hospira UK Limited v Cubist Pharmaceuticals LLC, United Kingdom
-
USA: Merck Sharp & Dohme Corp. v. Hospira, Inc., United States Court of Appeals, Federal Circuit, No. 2017-1115, 26 October 2017
-
Despite FCC ruling, Germany wants to push ahead with Unitary Patent system
-
Patent case: Innovative Memory Systems Inc. v. Micron Technology Inc., USA
-
Controversy in the Netherlands about Novartis orphan drug pricing
-
German complaint threatens future Unitary Patent system